NEWS & EVENTS

TriRx Shortlisted for the Excellence in Pharma: Innovation in Response to COVID-19 Award

TriRx is honored to be on the Excellence in Pharma: Innovation in Response to COVID-19 shortlist for the CPhI Pharma Awards 2021. These awards are designed to recognize the innovation and dedication of companies and individuals driving the pharmaceutical industry forward. CPhI Pharma Award winners will be announced at an award ceremony on November 9, 2021, Fiera Milano, Milan, Italy.  

 

TriRx is honored to be on the Excellence in Pharma: Innovation in Response to COVID-19 shortlist for the CPhI Pharma Awards 2021. These awards are designed to recognize the innovation and dedication of companies and individuals driving the pharmaceutical industry forward. CPhI Pharma Award winners will be announced at an award ceremony on November 9, 2021, Fiera Milano, Milan, Italy.  
 
During the global COVID-19 crisis, TriRx’ Huntsville facility team upgraded their site to allow for Hand Sanitizer production. The manufacturing areas were upgraded to ‘explosion proof,’ tanks outfitted with necessary mixing capabilities as well as installed and qualified three explosion proof packaging lines. In a seven-month period, the site manufactured 11,433,040 bottles of hand sanitizer which deterred the spread of COVID-19.
 
As a rapidly growing CDMO with now three facilities — Huntsville, Alabama, Shawnee, Kansas, Segré, France and Liverpool, England — TriRx proudly and consistently delivers quality, customer-focused human and animal health services through our dedicated team with decades of pharmaceutical manufacturing industry experience.
 
Learn more about the CPhI Pharma Awards 2021